Prescription Required
Encorate Chrono 333/145 mg Tablet CR is a controlled-release medication used to treat epilepsy and bipolar disorder. It contains Sodium Valproate (333 mg) and Valproic Acid (145 mg), which work together to control seizures, stabilize mood, and manage nerve-related conditions.
It is commonly prescribed for epilepsy, bipolar disorder, and migraine prevention, ensuring steady drug release for long-lasting effects.
With Encorate Chrono Tablet CR requires regular liver function tests; use with caution.
Patients with kidney disease should consult a doctor before using Encorate Chrono Tablet CR.
Avoid alcohol; may worsen dizziness and liver effects.
It may cause side effects that impair driving ability.
It is not considered to be safe for the pregnant women as it may cause birth defects.
It is not considered to be safe for mothers who breastfed their infants, use only under medical supervision.
Dual-Action Formula for Seizure & Mood Control. Sodium Valproate (333 mg) – Increases gamma-aminobutyric acid (GABA) levels, calming nerve activity and preventing seizures. Valproic Acid (145 mg) – Regulates electrical signals in the brain, reducing abnormal activity that causes seizures and mood swings. Together, these components prevent excessive nerve signals, making Encorate Chrono effective for epilepsy, bipolar disorder, and migraine prevention.
Epilepsy is a neurological disorder where nerve signals in the brain become abnormal, causing seizures, loss of awareness, or convulsions. Bipolar disorder is a mental health condition that causes extreme mood swings between high (mania) and low (depression).
Encorate Chrono 333/145 mg Tablet CR is a trusted anti-epileptic and mood stabilizer, widely used for seizure control, bipolar disorder, and migraine prevention. Its controlled-release formula ensures steady, long-lasting effects for better patient outcomes.
Content Updated on
Thursday, 20 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA